Mr. Michel Sidibe, the African Special Envoy for the African Medicine Agency (AMA), held a virtual meeting with a section of African representatives to the…
The Global Fund 7th replenishment investment case was unveiled during the Global Fund preparatory meeting, that was hosted virtually by a coalition of five countries…
A new HIV variant, more virulent and contagious, has emerged. This variant, known as VB, causes an early onset of opportunistic diseases, however It could…
The fight against HIV, TB and malaria is very often focused on an exclusively hygienic, therapeutic or biomedical approach. This paper does not question the…
Following the case of Rwanda, one of the GF grants’ implementing countries, the Community Health Program was instituted in 1995 and started with just about…
The Sustainability, Transition and Co-financing policy follows the Global Fund’s principle of additionality – the GF adds to local resources to fight the three diseases,…
Globally, new HIV infections declined by 44% between 2000 and 2021, missing the global target for a 75% reduction in new infections by 2020. The…
Health has long been a complicated and tragic topic in Africa. By April 2001, Southern African Development Community (SADC) governments together with other African Union…
The Global Fund’s new 2020-2023 grant implementation cycle has been launched with the expectation that it will produce greater results in the 23 countries of…
The two African constituencies are represented mostly in pairs at the Global Fund three committees (the Strategy, Ethics and Governance; and at the Audit and…